Add to ORKGThe present invention comprises pharmaceutical compositions comprising a co-crystal of an API and a co-crystal former, and methods of making and using the same
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
ABSTRACT Pharmaceutical materials science being a fundamental branch that continuously provides impo...
Most recently discovered active pharmaceutical molecules and market-approved medicines are poorly so...
The present invention comprises pharmaceutical compositions comprising a co-crystal of an API and a ...
A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the ...
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
Co-crystals comprising at least one nutraceutical compound and at least one co-crystal former with o...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
ABSTRACT: Co-crystals consists of API and a stoichiometric amount of a pharmaceutically acceptable c...
Combining APIs with specific molecules in a single crystal form shows potential during the developme...
Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative med...
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific p...
A growing number of co-crystals in the literature are proof of how significant the co-crystallizati...
A cocrystal having the formula LiX.aM, or a solvate or hydrate thereof, wherein X is a conjugate bas...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
ABSTRACT Pharmaceutical materials science being a fundamental branch that continuously provides impo...
Most recently discovered active pharmaceutical molecules and market-approved medicines are poorly so...
The present invention comprises pharmaceutical compositions comprising a co-crystal of an API and a ...
A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the ...
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
Co-crystals comprising at least one nutraceutical compound and at least one co-crystal former with o...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
ABSTRACT: Co-crystals consists of API and a stoichiometric amount of a pharmaceutically acceptable c...
Combining APIs with specific molecules in a single crystal form shows potential during the developme...
Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative med...
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific p...
A growing number of co-crystals in the literature are proof of how significant the co-crystallizati...
A cocrystal having the formula LiX.aM, or a solvate or hydrate thereof, wherein X is a conjugate bas...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
ABSTRACT Pharmaceutical materials science being a fundamental branch that continuously provides impo...
Most recently discovered active pharmaceutical molecules and market-approved medicines are poorly so...